Status Epilepticus Market Analysis By Type, (Conclusive Epilepticus, Non-conclusive Epilepticus), By Condition (Epilepsy Drug Resistant, Intractable Epilepsy, Others), By Drug (Ganaxolone, Diazepam, Fosphenytoin, Valproate, Phenobarbital, Phenytoin, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, online Pharmacies and Others) & Forecast 2024-2035
- PUBLISHED ON
- 24/03/2023
- NO OF PAGES
- 249
- CATEGORY
- Healthcare & Life Sciences
Status Epilepticus (SE) is a medical emergency that occurs when a person experiences continuous seizures or recurrent seizures without regaining consciousness between them. It is a life-threatening condition that requires immediate medical attention to prevent brain damage, disability, or death.
The market for SE treatments is relatively small, as SE is a rare condition that affects about 40-50 individuals per 100,000 people per year. However, the market is expected to grow in the coming years due to the increasing incidence of SE in older adults, especially those with comorbidities such as stroke, brain injury, or neurodegenerative disorders.
Currently, the treatment options for SE include intravenous (IV) medications such as benzodiazepines, phenytoin, and barbiturates, as well as other treatments such as ketogenic diet, immunotherapy, and surgical intervention. However, these treatments have limitations and side effects, and there is a need for safer and more effective therapies.
Several companies are working on developing new drugs for SE, including intranasal formulations of benzodiazepines, novel antiepileptic drugs, and neuroprotective agents. In addition, there is increasing interest in using medical cannabis for SE, although more research is needed to determine its efficacy and safety.
The market for SE treatments is expected to continue to grow as the incidence of SE increases and as new treatments become available. However, the market is also facing challenges such as high treatment costs, limited access to healthcare, and regulatory hurdles. Despite these challenges, there is a growing need for effective treatments for SE, and the market is expected to remain competitive and dynamic in the coming years.
Segment Overview
The Status Epilepticus (SE) market can be segmented based on several factors, including:
• Treatment type: The market can be segmented based on the type of treatment, such as intravenous medications, ketogenic diet, immunotherapy, and surgical intervention.
• Route of administration: The market can be segmented based on the route of administration, such as intravenous, intranasal, oral, or sublingual.
• End-users: The market can be segmented based on the end-users, such as hospitals, clinics, and ambulatory surgical centers.
• Type of seizure: The market can also be segmented based on the type of seizure, such as convulsive and non-convulsive SE.
• Age group: The market can be segmented based on the age group, such as paediatric and adult SE.
• Comorbidities: The market can also be segmented based on the underlying comorbidities, such as stroke, brain injury, or neurodegenerative disorders.
• Geography: The market can be segmented based on geography, such as North America, Europe, Asia-Pacific, and Rest of the World.
These segments can help companies to target specific patient populations, tailor their marketing strategies, and develop more effective treatments for SE. However, it is important to note that some of these segments may overlap, and companies need to consider multiple factors when developing their product strategies.
Geography Overview
The Status Epilepticus (SE) market can be segmented based on geography, with the major regions being North America, Europe, Asia-Pacific, and Rest of the World.
• North America: The North American market is the largest for SE treatment due to the high incidence of SE in the region. The market is driven by the availability of advanced healthcare infrastructure, rising awareness about the condition, and increasing research and development activities by key players.
• Europe: The European market is the second-largest for SE treatment due to the growing incidence of SE in older adults, along with increasing healthcare spending, and the presence of a large patient pool.
• Asia-Pacific: The Asia-Pacific market is expected to grow at the highest rate due to the increasing incidence of SE in the region, rising healthcare spending, and growing awareness about the condition. The market is also driven by the large patient pool, especially in countries such as India and China.
• Rest of the World: The Rest of the World market includes regions such as Latin America and the Middle East and Africa. The market is driven by the increasing incidence of SE in these regions, rising healthcare spending, and growing awareness about the condition.
Overall, the SE market is expected to grow in all regions due to the increasing incidence of SE and the need for more effective treatments. However, each region presents unique challenges and opportunities, and companies need to consider regional factors when developing their product strategies.
COVID Impact
The COVID-19 pandemic has had a significant impact on the Status Epilepticus (SE) market, as it has on many other healthcare sectors. Some of the impacts of COVID-19 on the SE market include:
1. Delayed diagnosis and treatment: Many patients with SE were not able to receive timely diagnosis and treatment due to restrictions on hospital visits and reduced availability of healthcare professionals.
2. Reduced access to care: Some patients with SE were not able to access care due to lockdowns, travel restrictions, and other pandemic-related factors.
3. Disruptions in clinical trials: The pandemic has disrupted ongoing clinical trials for SE treatments, causing delays and impacting research and development efforts.
4. Supply chain disruptions: The pandemic has disrupted the supply chains for SE treatments, leading to shortages of critical medications and medical supplies.
5. Financial impact: The pandemic has resulted in financial challenges for many patients, healthcare providers, and companies involved in SE treatment, which may impact access to care and research and development efforts.
Overall, the COVID-19 pandemic has had a negative impact on the SE market, with reduced access to care, delayed diagnosis and treatment, and disruptions in clinical trials and supply chains. However, the market is expected to recover as vaccination rates increase and healthcare systems adapt to the pandemic, with continued demand for effective treatments for SE.
Competitive Analysis
The Status Epilepticus (SE) market is highly competitive, with several companies developing and marketing treatments for this condition. Some of the key players in the SE market include:
• UCB Biopharma: UCB Biopharma is a global biopharmaceutical company that focuses on developing treatments for neurological and immunological disorders, including SE. Its SE treatment portfolio includes intravenous medications such as Keppra and Briviact.
• Pfizer Inc.: Pfizer is a leading global pharmaceutical company that offers several SE treatments, including intravenous medications such as Cerebyx and Phenytoin.
• H. Lundbeck A/S: Lundbeck is a Danish pharmaceutical company that focuses on developing treatments for neurological and psychiatric disorders, including SE. Its SE treatment portfolio includes intravenous medications such as Sabril and Onfi.
• Eisai Co., Ltd.: Eisai is a Japanese pharmaceutical company that offers several SE treatments, including intravenous medications such as Fycompa and Inovelon.
• Sun Pharmaceutical Industries Ltd.: Sun Pharma is an Indian multinational pharmaceutical company that offers SE treatments such as Levetiracetam and Midazolam.
Other key players in the SE market include Sage Therapeutics, Marinus Pharmaceuticals, Neurocrine Biosciences, Inc., and Neurelis, Inc.
These companies compete on the basis of product portfolio, pricing, distribution, and marketing strategies. Some of the key trends in the SE market include the development of novel therapies, the increasing focus on precision medicine, and the growing adoption of digital therapeutics. As the demand for SE treatments continues to rise, companies will need to continue investing in research and development and adapting their strategies to stay competitive in this market.
Historic Year: 2016-2022
Forecast: 2024-2035
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI